Double-Blind Randomized Controlled Trial of A1Cantus Drink vs. Placebo for Reduction of Ha1c
University of California, Riverside
Summary
The investigators will conduct a randomized controlled 2-arm parallel trial of A1c Drink vs. Placebo over a 3-month period and compare changes in Ha1c from baseline to 3 months. Investigator and study personnel, as well as participants, will be blinded to drink assignments.
Eligibility
- Age range
- 21–75 years
- Sex
- All
- Healthy volunteers
- Yes
Inclusion Criteria: * Adults 21 years of age or older and not older than 75 recruited from UCR Health * Clinical diagnosis of type II DM with Ha1c \>= 8 but less than or equal to 10 * Stable medications for at least 6 months * Speak Spanish and/or English * Sign an informed consent form * No other members in their household are participating in the study Exclusion Criteria: * Patients \<21 years of age, who do not have type II DM, whose Ha1c is less than 8 or \> 10, * Have major complications of diabetes, including CKD, diabetic retinopathy, ADVD risk \> 5, or history of CVD/stroke * Do not…
Interventions
- Dietary SupplementA1C Drink
In the experimental arm, participants will drink the A1C drink BID for 3 months as instructed. Both the active and placebo drinks will be identical in can size (12 oz slim can), packaging format, and visual appearance.
- OtherPlacebo drink
In the placebo arm, participants will drink the placebo drink BID for 3 months as instructed. Both the active and placebo drinks will be identical in can size (12 oz slim can), packaging format, and visual appearance.
Location
- UCR HealthRiverside, California